Liabilities, Current in USD of Humacyte, Inc. from Q3 2020 to Q3 2025

Taxonomy & unit: us-gaap: USD
Description: Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary: Humacyte, Inc. quarterly Liabilities, Current history and change rate from Q3 2020 to Q3 2025.
Humacyte, Inc. Liabilities, Current for the quarter ending 30 Sep 2025 was $25.6M, a 22.2% increase year-over-year.

Liabilities, Current, Quarterly (USD)

Liabilities, Current, YoY Quarterly Change (%)

Humacyte, Inc. Quarterly Liabilities, Current (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2025	$25.6M	+$4.64M	+22.2%	30 Sep 2025	10-Q	12 Nov 2025
Q2 2025	$21.1M	+$3.33M	+18.7%	30 Jun 2025	10-Q	11 Aug 2025
Q1 2025	$20M	+$5.94M	+42.2%	31 Mar 2025	10-Q	13 May 2025
Q4 2024	$20M	+$1.51M	+8.19%	31 Dec 2024	10-Q	12 Nov 2025
Q3 2024	$20.9M	+$5.81M	+38.4%	30 Sep 2024	10-Q	08 Nov 2024
Q2 2024	$17.8M	+$6.37M	+55.9%	30 Jun 2024	10-Q	13 Aug 2024
Q1 2024	$14.1M	-$9.51M	-40.3%	31 Mar 2024	10-Q	13 May 2024
Q4 2023	$18.4M	-$1.14M	-5.81%	31 Dec 2023	10-K	31 Mar 2025
Q3 2023	$15.1M	-$2.77M	-15.5%	30 Sep 2023	10-Q	09 Nov 2023
Q2 2023	$11.4M	+$330K	+2.98%	30 Jun 2023	10-Q	14 Aug 2023
Q1 2023	$23.6M	+$12.8M	+119%	31 Mar 2023	10-Q	12 May 2023
Q4 2022	$19.6M	+$8.53M	+77.2%	31 Dec 2022	10-K	28 Mar 2024
Q3 2022	$17.9M	-$3.34M	-15.7%	30 Sep 2022	10-Q	10 Nov 2022
Q2 2022	$11.1M	+$10.8M	+4930%	30 Jun 2022	10-Q	12 Aug 2022
Q1 2022	$10.8M	+$10.6M	+7835%	31 Mar 2022	10-Q	13 May 2022
Q4 2021	$11.1M	-$183K	-1.63%	31 Dec 2021	10-K	24 Mar 2023
Q3 2021	$21.2M	+$21.1M	+17535%	30 Sep 2021	10-Q	15 Nov 2021
Q2 2021	$220K			30 Jun 2021	10-Q	16 Aug 2021
Q1 2021	$136K			31 Mar 2021	10-Q	17 May 2021
Q4 2020	$11.2M			31 Dec 2020	10-K	29 Mar 2022
Q3 2020	$120K			30 Sep 2020	10-Q	13 Nov 2020

* An asterisk sign (*) next to the value indicates that the value is likely invalid.